The 18th Annual Conference on Statistical Issues in Clinical Trials will be held on April 20, 2026 in the Rubenstein Auditorium & Commons at the Perelman School of Medicine's Smilow Center for Translational Research (3400 Civic Center Boulevard, Philadelphia, PA).
Biomarkers have multiple uses in clinical trials, serving as diagnostic tools for patient selection, prognostic and predictive indicators of outcome, and in some cases endpoints themselves. Biomarkers can be used to improve the efficiency of clinical trial design and analysis and are central to the concept of personalized medicine. This year's UPenn Statistical Issues in Clinical Trials Conference brings together experts in the field to describe current frontiers in biomarker research. In addition to formal presentations and panel discussion, we include time for audience questions and comments.
This is a hybrid conference offering in-person and virtual options. In-person registration includes breakfast and lunch with multiple opportunities for networking. Those attending virtually have access to all formal program elements and can submit questions and comments online for inclusion in the audience discussion.
Speakers include:
Mei-Yin Polley, PhD, (U Chicago)
Thomas Jaki ,PhD, (U Regensburg and Cambridge)
Nigel Stallard, PhD, (U Warwick)
Lindsay Renfro ,PhD (USC)
Erica Moodie, PhD, (McGill U)
Jack Wolf, PhD, (UPenn)
Peter Gilbert, PhD (U Washington)
Our Panelists are:
Peter Thall, PhD, MD Anderson
Jianchang Lin, PhD, Takeda Pharmaceuticals
Dean Follman, PhD, NIH/NIAID Alumnus
Joseph Koopmeiners, U Minnesota